#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Metabolic disorder Chronic lymphocytic leukaemia refractory Amyloidosis Gaucher's disease type III Gestational trophoblastic tumour Ehlers-Danlos syndrome Neuromyelitis optica spectrum disorder Transitional cell carcinoma Immune thrombocytopenia Liver abscess Soft tissue sarcoma Transferrin decreased Hairy cell leukaemia Rhabdoid tumour Cytomegalovirus infection More trials…

    Learn about Rare Diseases

    VEXAS syndrome Hereditary ataxia – Basic Information Waldenstrom’s macroglobulinaemia – Basic Information Adrenocortical carcinoma – Diagnostics VEXAS syndrome – Treatment Retinitis pigmentosa – Diagnostics Lysosomal storage disorder – Treatment Turner’s syndrome – Basic Information Choroid melanoma – Treatment Glomerulonephritis membranous – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    VG801-1 Tradipitant Valproic Acid Naporafenib Gskvx000000014593 Tacrolimus Monohydrate Ethanol, Anhydrous Hydrochlorothiazide Sodium Oxybate Cetrorelix Olodaterol Quercus Ilex Allergen Extract Benzathine Benzylpenicillin Cabergoline Ropeginterferon Alfa-2B Amisulpride Ptg-Carcik-Cd19 Tyra-300-B01 Gedatolisib Dsimc More therapies…

    Learn about Your Condition

    Phenylketonuria Diarrhoea Frontotemporal dementia Pericarditis Craniosynostosis Rheumatic disorder Langerhans cell sarcoma Pterygium Atrial fibrillation Acute cardiac event Poor quality sleep Acoustic neuroma Pouchitis Myeloid leukaemia Pulmonary congestion More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Safety and Efficacy of AST-004 in Patients with Mild Complicated Traumatic Brain Injury

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Craniocerebral injury
    The Netherlands

  • Efficacy of Sivelestat in Patients with Septic Coagulopathy: A Phase IIb Randomized Controlled Trial

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Sodium Chloride Ph. Eur.
    • Sodium Hydrogen Carbonate Pheur
    France

  • Montelukast Sodium for disease-modifying treatment in patients with mild‑moderate Parkinson’s disease: open‑label phase II extension study

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Montelukast Sodium
    Sweden

  • Ticagrelor versus placebo to prevent cerebral ischemia in patients with low‑grade aneurysmal subarachnoid hemorrhage

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • Ticagrelor
    France

  • Prevention of radiation-induced salivary gland damage using botulinum toxin type A in patients with head and neck cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Botulinum Toxin Type A
    Czechia

  • Prognostic H2[15O] PET Imaging Study in Patients with Coronary Artery Disease Using O15‑Water, Adenosine and Regadenoson

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Coronary artery disease
    Investigated Drugs:
    • O15-Water
    • Regadenoson
    • Adenosine
    Sweden
Previous Page
1 … 701 702 703 704 705 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!